business
Popular antidepressant recalled over high levels of a cancer-causing compound
Summary by Frisco News Editorial Desk · Byline on the source page: Danielle Abreu , as published by NBC 5 Dallas-Fort Worth (KXAS) - Top Stories
· June 19, 2026
· 1 min read
Story provenance No corrections
Summary created by Frisco News Editorial Desk — automated, rule-governed Byline on source page Danielle Abreu, as published by NBC 5 Dallas-Fort Worth (KXAS) - Top Stories Original story Read at the source Source published Jun 19, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points Further information about the recall can be found through NBC 5 Dallas-Fort Worth, including details about the specific drug and the company involved, Breckenridge Pharmaceuticals. The problem was discovered by the company that makes it, which is based in New Jersey.
Medication used to treat certain conditions is being pulled from the market. This is due to concerns over its safety.
In this case, the issue is with a generic version of a well-known drug. The problem was discovered by the company that makes it, which is based in New Jersey.
Further information about the recall can be found through NBC 5 Dallas-Fort Worth, including details about the specific drug and the company involved, Breckenridge Pharmaceuticals.
More business Today’s briefing Local events
Why this story is here
NBC 5 Dallas-Fort Worth (KXAS) - Top Stories reported and published this story. Frisco News selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by NBC 5 Dallas-Fort Worth (KXAS) - Top Stories . Frisco News selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC 5 Dallas-Fort Worth (KXAS) - Top Stories . Have a tip or correction? Contact the editor .
Category: business ·
Published: June 19, 2026 ·
Source: NBC 5 Dallas-Fort Worth (KXAS) - Top Stories ·
Reading time: 1 min
Frequently asked about this story
What is this story about? Medication used to treat certain conditions is being pulled from the market. This is due to concerns over its safety. In this case, the issue is with a generic version of a well-known drug. The…
When was this published? This article was first published on June 19, 2026 by NBC 5 Dallas-Fort Worth (KXAS) - Top Stories and curated for Frisco News readers.
Who reported this story? This story was reported by Danielle Abreu at NBC 5 Dallas-Fort Worth (KXAS) - Top Stories. To learn more about how Frisco News selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more business coverage from Frisco News, or browse our daily briefing and topic hubs .
← Back to all news
More business →
Today’s briefing
Subscribe to newsletter